Dr Arvind Arumainathan

Dr Arumainathan completed undergraduate training at the University of Liverpool and the majority of his postgraduate training has been in the Mersey region. His primary clinical focus is lymphoid malignancy; lymphoma and chronic lymphocytic leukaemia (CLL). Locally, he is the lead for cutaneous lymphoma (skin lymphoma), and lymphoma in people living with HIV. 

Dr Arumainathan participates actively in clinical research and is the local principal investigator for several studies. He is also a clinical co-ordinator for national lymphoma/CLL trials at the Liverpool Cancer Trials Unit. He has an interest in medical education and is actively involved in teaching and training.